Mr. Bryan Baldasare - 15 Dec 2021 Form 4 Insider Report for MERIDIAN BIOSCIENCE INC

Reporting relationship: Exec VP & CFO
Issuer ticker: N/A
Reported as of: 15 Dec 2021
Net transaction value: -$35,571
SEC form: 4
Accepted by SEC: 22 Dec 2021, 07:17:10 UTC
Prior SEC filing: 16 Nov 2021
Next SEC filing: 19 May 2022
Source filing: View source filing
Reporting owner signature: /s/ Bryan T. Baldasare

Key filing fact

Mr. Bryan Baldasare filed Form 4 for MERIDIAN BIOSCIENCE INC on 22 Dec 2021.

Key facts

This page summarizes Mr. Bryan Baldasare's Form 4 filing for MERIDIAN BIOSCIENCE INC.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Dec 2021, 07:17.

Change

Previous filing in this sequence was filed on 16 Nov 2021.
Current net transaction value: -$35,571.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VIVO transaction

Common Stock

Tax liability

Transaction value: $35,571
Shares: -1,985
Change %: -3.2%
Price: $17.92
Shares after: 60,929
Date: 15 Dec 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represent restricted stock units withheld by the Company under the net share settlement method to cover certain taxes due related to retirement eligibility, as follows: (i) 487 granted November 4, 2021; and (ii) 1,498 granted November 15, 2021.